Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples